Modulation of p38 MAPK activity in regulatory T cells after tolerance with anti-DNA Ig peptide in (NZB X NZW)F1 lupus mice

Journal of Immunology

Volumn 182, Issue 12, 2009, Pages 7415-7421

  Lourenço, Elaine V ^a   Procaccini, Claudio ^a,c   Ferrera, Francesca ^a,e   Iikuni, Noriko ^a   Singh, Ram P ^a   Filaci, Gilberto ^b   Matarese, Giuseppe ^c   Shi, Fu Dong ^d   Brahn, Ernest ^a   Hahn, Bevra H ^a   Cava, Antonio La ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d BARROW NEUROLOGICAL INSTITUTE   (United States)

^e UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; DNA ANTIBODY; IMMUNOGLOBULIN ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE ZAP 70; PROTEIN P27; STAT1 PROTEIN; STAT3 PROTEIN; STAT6 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; DNA; IMMUNOGLOBULIN; PEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SINGLE DRUG DOSE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; ANIMAL; CD4 LYMPHOCYTE COUNT; CYTOLOGY; DOWN REGULATION; DRUG EFFECT; ENZYMOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; SURVIVAL RATE;

ANIMALS; CD4 LYMPHOCYTE COUNT; DNA; DOWN-REGULATION; ENZYME ACTIVATION; FEMALE; IMMUNE TOLERANCE; IMMUNOGLOBULINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDES; SURVIVAL RATE; T-LYMPHOCYTES, REGULATORY;

EID: 67649213042     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0804214     Document Type: Article

References (33)

1. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155: 1151-1164.
2. Asano, M., M. Toda, N. Sakaguchi, and S. Sakaguchi. 1996. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184: 387-396. (Pubitemid 26324092)
3. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22: 531-562.
4. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2: 389-400.
5. La Cava, A. 2008. T-regulatory cells in systemic lupus erythematosus. Lupus 17: 421-425. (Pubitemid 351798720)
6. + T cells from tolerized (New Zealand Black X New Zealand White)F1 mice suppress in vitro production of antibodies to DNA. J. Immunol. 173: 3542-3548.
7. Chang, L., and M. Karin. 2001. Mammalian MAP kinase signalling cascades. Nature 410: 37-40.
8. Cook, R., C. C. Wu, Y. J. Kang, and J. Han. 2007. The role of the p38 pathway in adaptive immunity. Cell. Mol. Immunol. 4: 253-259.
9. Hahn, B. H., R. R. Singh, W. K. Wong, B. P. Tsao, K. Bulpitt, and F. M. Ebling. 2001. Treatment with a consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupus. Arthritis Rheum. 44: 432-441.
10. De Rosa, V., C. Procaccini, G. Calì, G. Pirozzi, S. Fontana, S. Zappacosta, A. La Cava, and G. Matarese. 2007. A key role of leptin in the control of regulatory T cell proliferation. Immunity 26: 241-255.
11. + T cell suppressors. J. Immunol. 175: 7728-7737.
12. Peng, T., X. Lu, M. Lei, G. W. Moe, and Q. Feng. 2003. Inhibition of p38 MAPK decreases TNF-α expression and improves myocardial function and survival in endotoxemia. Cardiovasc. Res. 59: 893-900.
13. Lourenço, E. V., and A. La Cava. 2009. Cytokines in systemic lupus erythematosus. Curr. Mol. Med. 9: 242-254.
14. + T cell-mediated suppression of autoimmunity in a murine lupus model of peptideinduced immune tolerance depends on Foxp3 expression. J. Immunol. 178: 7649-7657.
15. 1 mice by differentially regulating Foxp3 and PD1 molecules. J. Immunol. 180: 2069-2080.
16. Ashwell, J. D. 2006. The many paths to p38 mitogen-activated protein kinase activation in the immune system. Nat. Rev. Immunol. 6: 532-540.
17. + regulatory T cells. Front. Biosci. 13: 1440-1446.
18. + regulatory and natural killer-like T cells on signals leading to NF-κB activation. Proc. Natl. Acad. Sci. USA 101: 4566-4571.
19. Matarese, G., V. De Rosa, and A. La Cava. 2008. Regulatory CD4 T cells: sensing the environment. Trends Immunol. 29: 12-17.
20. + suppressor T cells in vivo. Nat. Immunol. 3: 33-41.
21. + regulatory T cells fail to undergo chromatin remodeling across the proximal promoter region of the IL-2 gene. J. Immunol. 173: 4994-5001.
22. Chan, S. M., J. Ermann, L. Su, C. G. Fathman, and P. J. Utz. 2004. Protein microarrays for multiplex analysis of signal transduction pathways. Nat. Med. 10: 1390-1396.
23. Crow, M. K., K. A. Kirou, and J. Wohlgemuth. 2003. Microarray analysis of interferon-regulated genes in SLE. Autoimmunity 36: 481-490.
24. Kirou, K. A., C. Lee, S. George, K. Louca, I. G. Papagiannis, M. G. Peterson, N. Ly, R. N. Woodward, K. E. Fry, A. Y. Lau, et al. 2004. Coordinate overexpression of interferon-α-induced genes in systemic lupus erythematosus. Arthritis Rheum. 50: 3958-3967.
25. Sharabi, A., and E. Mozes. 2008. The suppression of murine lupus by a tolerogenic peptide involves Foxp3-expressing CD8 cells that are required for the optimal induction and function of Foxp3-expressing CD4 cells. J. Immunol. 181: 3243-3251.
26. + T cell-mediated suppression by dendritic cells. Science 299: 1033-1036.
27. + regulatory T cells. J. Immunol. 181: 6923-6933.
28. Adler, H. S., S. Kubsch, E. Graulich, S. Ludwig, J. Knop, and K. Steinbrink. 2007. Activation of MAP kinase p38 is critical for the cell-cycle-controlled suppressor function of regulatory T cells. Blood 109: 4351-4359.
29. Wilczynski, J. R., M. Radwan, and J. Kalinka. 2008. The characterization and role of regulatory T cells in immune reactions. Front. Biosci. 13: 2266-2274.
30. -T cells into iTreg. PLoS ONE 3: e3302.
31. Mihara, K., C. Almansa, R. L. Smeets, E. E. Loomans, J. Dulos, P. M. Vink, M. Rooseboom, H. Kreutzer, F. Cavalcanti, A. M. Boots, and R. L. Nelissen. 2008. A potent and selective p38 inhibitor protects against bone damage in murine collagen-induced arthritis: a comparison with neutralization of mouse TNFα. Br. J. Pharmacol. 154: 153-164.
32. Badger, A. M., D. E. Griswold, R. Kapadia, S. Blake, B. A. Swift, S. J. Hoffman, G. B. Stroup, E. Webb, D. J. Rieman, M. Gowen, et al. 2000. Disease-modifying activity of SB242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis. Arthritis Rheum. 43: 175-183.
33. lpr mice. J. Am. Soc. Nephrol. 14: 57-67.